![Rufus W. Burlingame](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rufus W. Burlingame
Corporate Officer/Principal presso Genalyte, Inc.
Profilo
Rufus W.
Burlingame is currently the Vice President-Diagnostic Assay Development at Genalyte, Inc. He previously worked as a Research Director-Reference Laboratory at The Scripps Research Institute, a Principal at The University of New Mexico, and a Vice President-Research & Development at INOVA Diagnostics, Inc. He holds a doctorate degree from The Johns Hopkins University.
Posizioni attive di Rufus W. Burlingame
Società | Posizione | Inizio |
---|---|---|
Genalyte, Inc.
![]() Genalyte, Inc. Medical SpecialtiesHealth Technology Genalyte, Inc. specializes in instrumentation and multiplex assays for biomarker and protein detection. The firm offers autoantibody testing assays for autoimmune research, custom assay services and maverick detection system. The company was founded in 2007 by Lawrence Cary Gunn III and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/03/2013 |
Precedenti posizioni note di Rufus W. Burlingame
Società | Posizione | Fine |
---|---|---|
The Scripps Research Institute
![]() The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | Corporate Officer/Principal | - |
The University of New Mexico | Corporate Officer/Principal | - |
INOVA Diagnostics, Inc.
![]() INOVA Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology INOVA Diagnostics, Inc. manufactures and distributes autoimmune disease diagnostics markers. It provides IVD systems and reagents for hospitals and clinical laboratories. The company was founded in 1987 and is headquartered in San Diego, CA. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Rufus W. Burlingame
The Johns Hopkins University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
INOVA Diagnostics, Inc.
![]() INOVA Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology INOVA Diagnostics, Inc. manufactures and distributes autoimmune disease diagnostics markers. It provides IVD systems and reagents for hospitals and clinical laboratories. The company was founded in 1987 and is headquartered in San Diego, CA. | Health Technology |
Genalyte, Inc.
![]() Genalyte, Inc. Medical SpecialtiesHealth Technology Genalyte, Inc. specializes in instrumentation and multiplex assays for biomarker and protein detection. The firm offers autoantibody testing assays for autoimmune research, custom assay services and maverick detection system. The company was founded in 2007 by Lawrence Cary Gunn III and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Rufus W. Burlingame